Related Experiment Video
Updated: Mar 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
[A novel compound heterozygous mutation causing 3-methylcrotonyl-CoA carboxylase deficiency]
Bobo Xie1, Jingsi Luo, Yaqin Lei
1Department of Genetic Metabolism, Maternal and Children Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530003, China.
Objective:
To explore the molecular mechanism for a boy suspected with 3-methylcrotonyl-CoA carboxylase deficiency by neonatal screening.
Methods:
PCR and Sanger sequencing were used to identify potential mutations of MCCC1 and MCCC2 genes. SIFT and Polyphen-2 software was used to predict the effect of variant on the protein function and conservation of the variant across various species. Human Splicing Finder and Swiss-PdbViewer4.1.0 were applied to analyze the possible mechanism of the variant.
Results:
For the proband, a compound heterozygous mutation was discovered in the MCCC1 gene, namely c.539G>T (p.G180V) and c.704_711del (p.A235Vfs*4), which were inherited from his father and mother, respectively. The two mutations have disrupted the protein conformation, which in turn may impact the function of MCC protein.
Conclusion:
The compound heterozygous mutations of the MCCC1 gene may contribute to the 3-methylcrotonyl-CoA carboxylase deficiency manifested by the patient.
Related Concept Videos
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Inborn Errors of Metabolism
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids
Animal Mitochondrial Genetics
Amino Acid Catabolism
Translation
Translation Produces the Building Blocks of Life
Proteins are...

